BioTelemetry, operating under the brand Telcare, is a pioneer in the mobile and wireless medical technology industry. The company specializes in delivering health information to improve patient outcomes and reduce healthcare costs. BioTelemetry's core offerings include cardiac and mobile blood glucose monitoring, centralized medical imaging, and original equipment manufacturing, primarily serving the healthcare and clinical research sectors. The company's flagship product, the Telcare Blood Glucose Monitoring System, was the first FDA-cleared cellular glucose meter and is now in its third generation. This system is complemented by an advanced online patient and provider portal, enhancing the continuum of care. BioTelemetry's business model revolves around the sale of its medical devices and associated services, generating revenue through direct sales to healthcare providers and patients. The company leverages wireless and cellular M2M (machine-to-machine) technology to connect patients with caregivers, ensuring seamless health management. BioTelemetry's market includes hospitals, clinics, and research institutions that require reliable and innovative medical monitoring solutions. The company's commitment to innovation and quality care positions it as a leader in the remote medical technology space.

Keywords: cardiac monitoring, glucose monitoring, wireless technology, cellular M2M, FDA-cleared, healthcare, clinical research, medical imaging, patient care, health management.